Latest Articles

Publication Date
Unheard. Unserved: After costly U.S. surgery, endometriosis patient pushes for more options - unpublished.ca

Unheard. Unserved: After costly U.S. surgery, endometriosis patient pushes for more options unpublished.ca

Published: Nov. 13, 2025, 11:05 a.m.
Unheard. Unserved: After costly U.S. surgery, endometriosis patient pushes for more options - Unpublished Media

Unheard. Unserved: After costly U.S. surgery, endometriosis patient pushes for more options Unpublished Media

Published: Nov. 13, 2025, 11:05 a.m.
Unheard. Unserved: After costly U.S. surgery, endometriosis patient pushes for more options - Global News

Unheard. Unserved: After costly U.S. surgery, endometriosis patient pushes for more options Global News

Published: Nov. 13, 2025, 11 a.m.
MAMAVISION | Gabriela Kocev: I became a mother with a bicornuate uterus and endometriosis, the doctors called me a phenomenon - Слободен печат

MAMAVISION | Gabriela Kocev: I became a mother with a bicornuate uterus and endometriosis, the doctors called me a phenomenon Слободен печат

Published: Nov. 13, 2025, 10:57 a.m.
Clarivate Companies to Watch Report Spotlights Seven Women's Health Startups Shaping the Future of Care - The Malaysian Reserve

Clarivate Companies to Watch Report Spotlights Seven Women's Health Startups Shaping the Future of Care The Malaysian Reserve

Published: Nov. 13, 2025, 9:31 a.m.
FDA Approves Promega OncoMate® MSI Dx as Companion Diagnostic for KEYTRUDA® and LENVIMA® in Endometrial Cancer - Voice Of HealthCare

FDA Approves Promega OncoMate® MSI Dx as Companion Diagnostic for KEYTRUDA® and LENVIMA® in Endometrial Cancer Voice Of HealthCare

Published: Nov. 13, 2025, 6:17 a.m.
FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma - 뉴스와이어

FDA Approves Promega OncoMate® MSI Dx Analysis System as Companion Diagnostic for KEYTRUDA® in Combination with LENVIMA® In Advanced Endometrial Carcinoma 뉴스와이어

Published: Nov. 13, 2025, 5:50 a.m.
Absci Corp (ABSI) Q3 2025 Earnings Call Highlights: Strategic Shifts and Strong Cash Position ... By GuruFocus - Investing.com Canada

Absci Corp (ABSI) Q3 2025 Earnings Call Highlights: Strategic Shifts and Strong Cash Position ... By GuruFocus Investing.com Canada

Published: Nov. 13, 2025, 5:35 a.m.
Amy Schumer reveals why she deleted her pre-weight loss photos on Instagram - Page Six

Amy Schumer reveals why she deleted her pre-weight loss photos on Instagram Page Six

Published: Nov. 13, 2025, 2:47 a.m.
WRN Inhibitors Market Enters Growth Phase with Multiple Early-Stage Clinical Programs Underway | DelveInsight - The Malaysian Reserve

WRN Inhibitors Market Enters Growth Phase with Multiple Early-Stage Clinical Programs Underway | DelveInsight The Malaysian Reserve

Published: Nov. 12, 2025, 11:52 p.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!